Related Experiment Video
Updated: Jul 17, 2026

07:50
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
6.8K
Building an I2B2-Based Population Repository for Clinical Research
Lydia González1, David Pérez-Rey1, Enrique Alonso1
1Biomedical Informatics Group, Artificial Intelligence Department, E.T.S.I. Informáticos, Universidad Politécnica de Madrid, Spain.
Studies in Health Technology and Informatics
|June 24, 2020
Summary
This study details connecting Spain
Area of Science:
- Health Informatics
- Clinical Research Networks
Background:
- Hospitals generate vast amounts of data from disparate sources.
- Integrating this data into a unified format is crucial for research.
- The 12 de Octubre University Hospital faced challenges in data harmonization.
Purpose of the Study:
- To describe the process of connecting a hospital to the TriNetX research network.
- To detail the phases of data integration and semantic normalization.
- To highlight the research opportunities enabled by the InSite platform.
Main Methods:
- Phased integration of terminology core datasets and specialized sources.
- Implementation of automatic daily data refreshment.
- Semantic normalization of clinical terminologies using the InSite platform.
Main Results:
- Successful connection of 12 de Octubre University Hospital to the TriNetX network.
- Creation of a single, harmonized, and automatically updated data repository.
- Enhanced research capabilities through the InSite platform.
Conclusions:
- The integration process demonstrates a viable model for hospital data harmonization.
- Automated data refreshment ensures up-to-date information for research.
- The InSite platform significantly expands research opportunities for healthcare institutions.
Related Concept Videos
Hospitals-II
Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in hospitals have...
Nurses that work in hospitals have...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

